These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17270149)

  • 1. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells.
    Fukada K; Takahashi-Yanaga F; Sakoguchi-Okada N; Shiraishi F; Miwa Y; Morimoto S; Sasaguri T
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1166-71. PubMed ID: 17466271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin.
    Torres VA; Tapia JC; Rodríguez DA; Párraga M; Lisboa P; Montoya M; Leyton L; Quest AF
    J Cell Sci; 2006 May; 119(Pt 9):1812-23. PubMed ID: 16608879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
    Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
    J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
    Dihlmann S; Siermann A; von Knebel Doeberitz M
    Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
    Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
    Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.
    Kapitanović S; Cacev T; Antica M; Kralj M; Cavrić G; Pavelić K; Spaventi R
    Exp Mol Pathol; 2006 Feb; 80(1):91-6. PubMed ID: 15963497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
    Kim SH; Hwang CI; Juhnn YS; Lee JH; Park WY; Song YS
    Carcinogenesis; 2007 Jan; 28(1):223-31. PubMed ID: 17166886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells.
    Mandayam S; Huang R; Tarnawski AS; Chiou SK
    Apoptosis; 2007 Jun; 12(6):1109-16. PubMed ID: 17151952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway.
    Tang FY; Shih CJ; Cheng LH; Ho HJ; Chen HJ
    Mol Nutr Food Res; 2008 Jun; 52(6):646-54. PubMed ID: 18537129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
    Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
    Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.